PolyPid Ltd is a biopharma company that uses the PLEX platform to create medical products for unmet needs in the market. Their leading product, D-PLEX100, is currently undergoing Phase III clinical trials to prevent bone and soft tissue surgical site infections. Founded in 2008, the company is based in Petah Tikva, Israel.